Yasemin AKKUBAK, Erkan CÜRE, Adem KÜÇÜK, Şakir GICA, Zakire Kübra AKSOY

Effects of the COVID-19 pandemic on psychology and disease activity in patients with ankylosing spondylitis and rheumatoid arthritis

Background/aim: The COVID-19 outbreak is known to increase stress levels of most patients with chronic diseases. Patients with ankylosing spondylitis (AS) and rheumatoid arthritis (RA) are highly susceptible to environmental stress. In the current study, we aimed to determine how the COVID-19 pandemic psychologically affected patients with chronic progressive diseases such as AS and RA and the effects of these psychological factors on disease activity. Materials and methods: Age and sex-matched patients with AS (n = 80), RA (n = 80), and healthy controls (n = 80) were included in the study. All participants were evaluated with the “Perceived COVID-19 Threat Form (PCTF)”, “Suicide-Ideation Scale (SIS)”, “Hospital Anxiety and Depression Scale (HADS)”, “The Ability to Cope with Trauma (PACT)”, and “Psychological General Well-Being Index (PGWB)” scales. BASDAI was used in patients with AS, and DAS28 was used in patients with RA to assess disease severity. Results: Compared to healthy individuals, patients with RA and AS had lower PGWB scores and higher HADS depression and anxiety subscale scores. Almost all psychometric assessment test scores were worse in AS patients with high-disease activity compared to those in low-disease activity. PACT scores were higher in patients with moderate RA compared to patients with mild RA (p = 0.006). While a positive correlation was identified between BASDAI and most of the psychometric assessment test scores (r = 0 .36 for PCTF, r = 0.53 for depressive scores, r = 0.54 for anxiety scores, r = 0.57 for suicidal ideation), DAS28 scores were found to be associated only with PACT total and PACT perceived forward-focused subscale scores (r = –.26 and r = .33, respectively). Conclusion: Psychologically, AS and RA patients were found to be worse off compared to healthy controls. The perceived COVID threat and psychological status were associated with disease activity in AS, but not RA patients. Patients with chronic illnesses may be more vulnerable to the psychological effects of the pandemic, which can worsen disease activity.Key words: COVID-19, ankylosing spondylitis, rheumatoid arthritis, psychological well-being, disease activity, coping ability

PDF

___

1. Akhondi H, Varacallo M. Rheumatoid arthritis and ankylosing spondylitis. Treasure Island, FL, USA: StatPearls Publishing; 2020.
2. Barlow JH, Macey SJ, Struthers GR. Gender, depression and ankylosing spondylitis. Arthritis Care & Research 1993; 6: 45-51.
3. Ben Tekaya A, Mahmoud I, Hamdi I, Hechmi S, Saidane O et al. Depression and anxiety in spondyloarthritis: prevalence and relationship with clinical parameters and self-reported outcome measures. Turkish Journal of Psychiatry 2019; 30: 90-98.
4. Isik A, Koca SS, Ozturk A, Mermi O. Anxiety and depression in patients with rheumatoid arthritis. Clinical Rheumatology 2007; 26: 872–878.
5. Marrie RA, Hitchon CA, Walld R, Patten SB, Bolton JM et al. increased burden of psychiatric disorders in rheumatoid arthritis. arthritis care & research (Hoboken). 2018; 70 (7): 970-978.
6. Nicassio PM. Arthritis and psychiatric disorders: disentangling the relationship. Journal of Psychosomatic Research 2010; 68 (2): 183-5. doi: 10.1016/j.jpsychores.2009.09.008
7. Sundquist K, Li X, Hemminki K, Sundquist J. Subsequent risk of hospitalization for neuropsychiatric disorders in patients with rheumatic diseases: a nationwide study from Sweden. Archives of General Psychiatry 2008; 65 (5): 501–507. doi:10.1001/ archpsyc.65.5.501
8. Durmus D, Sarisoy G, Alayli G, Kesmen H, Çetin E et al. Psychiatric symptoms in ankylosing spondylitis: their relationship with disease activity, functional capacity, pain and fatigue. Comprehensive Psychiatry 2015; 62: 170-177. doi: 10.1016/j. comppsych.2015.07.016
9. Baysal O, Durmuş B, Ersoy Y, Altay Z, Senel K et al. Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis. Rheumatology International 2011; 31 (6): 795-800. doi: 10.1007/s00296-010-1381-x
10. Aktekin LA, Eser F, Başkan BM, Sivas F, Malhan S et al. Disability of Arm Shoulder and Hand Questionnaire in rheumatoid arthritis patients: relationship with disease activity, HAQ, SF-36. Rheumatology International 2011; 31 (6): 823-826. doi: 10.1007/ s00296-010-1568-1
11. Brooks SK, Dunn R, Amlôt R, Rubin GJ, Greenberg N. A systematic, thematic review of social and occupational factors associated with psychological outcomes in healthcare employees during an infectious disease outbreak. Journal of Occupational and Environmental Medicine 2018; 60: 248-257.
12. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S et al. The psychological impact of quarantine and how to reduce it: A rapid review of the evidence. Lancet 2020; 395: 912-920. doi: https:// doi.org/10.1016/S0140-6736(20)30460-8
13. Gica S, Kavakli M, Durduran Y, Ak M. The Effect of COVID-19 Pandemic on psychosomatic complaints and investigation of the mediating role of intolerance to uncertainty, biological rhythm changes and perceived COVID-19 threat in this relationship: a web-based community survey. Psychiatry and Clinical Psychopharmacology 2020; 30 (2): 89-96. doi:10.5455/ PCP.20200514033022
14. Sarısoy G, Durmuş D, Boke O, Canturk F, Şahin AR. Coping with stress and body image in patients with ankylosing spondylitis. Archives of Neuropsychiatry 2014; 51: 110-115.
15. Fortinasit KM, Holoday-Worret P. Psychiatric mental health nursing. 5th ed. St. Louis, MO, USA: Mosby; 1996.
16. Ciurea A, Papagiannoulis E, Bürki K, von Loga I, Micheroli R et al. Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort. Annals of the Rheumatic Diseases 2021; 80 (2): 238-241. doi: 10.1136/ annrheumdis-2020-218705
17. Fredi M, Cavazzana I, Moschetti L, Andreoli L, Franceschini F et al. COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case-control study. Lancet Rheumatology 2020; 2: e549-e56. doi: 10.1016/S2665- 9913(20)30169-7
18 Mancuso CA, Duculan R, Jannat-Khah D, Barbhaiya M, Bass AR et al. Rheumatic disease-related symptoms during the height of the COVID-19 pandemic. HSS Journal 2020; 18: 1-9 [ahead of print]. doi:10.1007/s11420-020-09798-w
19. Kucuk A, Vatansev H, Gica S, Demir S, Cure E. Effects of COVID-19 Pandemic on psychological condition and disease severity in patients with Behçet’s Disease. Psychiatry and Behavioral Sciences 2020; 10 (4): 168-177. doi: 10.5455/ PBS.20200913012956
20. Tee CA, Salido EO, Reyes PWC, Ho RC, Tee ML. psychological state and associated factors during the 2019 coronavirus disease (COVID-19) pandemic among filipinos with rheumatoid arthritis or systemic lupus erythematosus. Open Access Rheumatology 2020; 12: 215-222. doi: 10.2147/OARRR. S269889
21. Picchianti Diamanti A, Cattaruzza MS, Di Rosa R, Del Porto F, Salemi S et al. Psychological distress in patients with autoimmune arthritis during the COVID-19 induced lockdown in Italy. Microorganisms 2020; 8 (11): 1818. doi: 10.3390/microorganisms8111818
22. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods 2007; 39: 175-191. https://doi.org/10.3758/BF03193146
23. Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behavior Research Methods 2009; 41: 1149-1160. https://doi.org/10.3758/BRM.41.4.1149
24. Kavakli M, Ak M, Uguz F, Turkmen OO. The mediating role of selfcompassion in the relationship between perceived COVID-19 threat and death anxiety. Turkish Journal of Clinical Psychiatry 2020; 23 (1): 15-23. doi: 10.5505/kpd.2020.59862
25. Dilbaz N, Holat H, Bayam G, Berksun O, Holat H et al. Validity and reliability of suicide ideation scale. In: 31st Turkish National Congress of Psychiatry; İstanbul, Turkey. pp. 40-41. (In Turkish)
26. Aydemir O, Guvenir T, Kuey L, Kultur S. Reliability and validity of the Turkish version of Hospital Anxiety and Depression Scale. Turkish Journal of Psychiatry 1997; 8 (4): 280-287.
27. Bonanno GA, Pat-Horenczyk R, Noll J. Coping flexibility and trauma: The Perceived Ability to Cope with Trauma (PACT) scale. Psychological Trauma: Theory, Research, Practice, and Policy 2011; 3 (2): 117-129.
28. Ari E, Cesur-Soysal G. Perceived Ability to Cope with Trauma Scale (PACT): The Turkish adaptation, validity and reliability study. Journal of Clinical Psychology Research 2019; 3: 17-25.
29. Diener E, Wirtz D, Tov W, Kim-Prieto C, Choi D et al. New wellbeing measures: Short scales to assess flourishing and positive and negative feelings. Social Indicators Research 2010; 97: 143–156.
30. Telef BB. The Adaptation of Psychological Well-Being into Turkish: A validity and reliability study. Hacettepe University - Journal of Education 2013; 28 (3): 374-384.
31. Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H et al. Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology 1999; 38 (9): 878-882.
32. Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N. A Turkish version of the bath ankylosing spondylitis disease activity index: reliability and validity. Rheumatology International 2005; 25 (4): 280-284.
33. van Riel PL, Renskers L. The Disease Activity Score (DAS) and the Disease Activity Score using 28 joint counts (DAS28) in the management of rheumatoid arthritis. Clinical and Experimental Rheumatology 2016; 34 (Suppl 101): 40-44.
34. Tan YK, Li H, Allen JC Jr, Thumboo J. Anti-cyclic citrullinated peptide but not rheumatoid factor is associated with ultrasounddetected bone erosion among rheumatoid arthritis patients with at least moderate disease activity. International Journal of Rheumatic Disease 2020; 23 (10): 1337-1343. doi: 10.1111/1756- 185X.13933
35. Nam B, Koo BS, Lee TH, Shin JH, Kim JJ et al. Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study. BMC Musculoskelet Disorders 2021; 22 (1): 140. doi: 10.1186/s12891-020-03941-8
36. Kelly K. Ankylosing spondylitis and undifferentiated spondyloarthritis: The relationship between living with these diseases and psychological well-being. Musculoskeletal Care 2020 [ahead of print]. doi: 10.1002/msc.1513
37. Treharne GJ, Kitas GD, Lyons AC, Booth DA. Well-being in rheumatoid arthritis: the effects of disease duration and psychosocial factors. Journal of Health Psychology 2005; 10 (3): 457-74. doi: 10.1177/1359105305051416
38. Jobski K, Luque Ramos A, Albrecht K, Hoffmann F. Pain, depressive symptoms and medication in German patients with rheumatoid arthritis-results from the linking patient-reported outcomes with claims data for health services research in rheumatology (PROCLAIR) study. Pharmacoepidemiology and Drug Safe 2017; 26 (7): 766-774. doi: 10.1002/pds.4202
39. Bayram K, Erol A. Childhood traumatic experiences, anxiety, and depression levels in fibromyalgia and rheumatoid arthritis. Archives of Neuropsychiatry 2014; 51 (4): 344-349. doi:10.5152/ npa.2014.6958
40. Valtýsdóttir ST, Gudbjörnsson B, Hällgren R, Hetta J. Psychological well-being in patients with primary Sjögren’s syndrome. Clinical and Experimental Rheumatology 2000; 18 (5): 597-600.
41. Seyahi E, Poyraz BC, Sut N, Akdogan S, Hamuryudan V. The psychological state and changes in the routine of the patients with rheumatic diseases during the coronavirus disease (COVID-19) outbreak in Turkey: a web-based cross-sectional survey. Rheumatology Internatonal 2020; 22: 1-10 [ahead of print]. doi:10.1007/s00296-020-04626-0
42. Manzano García G, Ayala Calvo JC. The threat of COVID-19 and its influence on nursing staff burnout. Journal of Advanced Nursing 2020 [ahead of print]. doi: 10.1111/jan.14642
43. Spoorthy MS, Pratapa SK, Mahant S. Mental health problems faced by healthcare workers due to the COVID-19 pandemic-A review. Asian Journal of Psychiatry 2020; 51: 102119. doi:10.1016/j.ajp.2020.102119
44. Kachanoff FJ, Bigman YE, Kapsaskis K, Gray K. measuring realistic and symbolic threats of COVID-19 and their unique impacts on well-being and adherence to public health behaviors. Social Psychological and Personality Science 2020 [ahead of print]. doi:10.1177/1948550620931634
45. Dawel A, Shou Y, Smithson M, Cherbuin N, Banfield M et al. The Effect of COVID-19 on mental health and wellbeing in a representative sample of Australian Adults. Front Psychiatry 2020; 11: 579985. doi: 10.3389/fpsyt.2020.579985
46. López-Medina C, Ladehesa-Pineda L, Gómez-García I, Ángeles Puche-Larrubia M, Miguel Sequí-Sabater J et al. Treatment adherence during the COVID-19 pandemic and the impact of confinement on disease activity and emotional status: a survey in 644 rheumatic patients. Joint Bone Spine 2020 27: 105085 [ahead of print]. doi: 10.1016/j.jbspin.2020.105085
47. Ciurea A, Papagiannoulis E, Bürki K, Von Loga I, Micheroli R et al. Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort. Annals of the Rheumatic Diseases 2020; 0: 1-4 [ahead of print]. doi:10.1136/ annrheumdis-2020-218705
48. Woo AK. Depression and anxiety in pain. Reviews in Pain 2010; 4 (1): 8-12. doi:10.1177/204946371000400103
49. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L et al. A meta-analysis of cytokines in major depression. Biological Psychiatry 2010; 67 (5): 446-457.
50. Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nature Reviews Immunology 2016; 16 (1): 22-34.
51. Sheng J, Liu S, Wang Y, Cui R, Zhang X. The link between depression and chronic pain: neural mechanisms in the brain. Neural Plasticity 2017; 2017: 9724371. doi: 10.1155/2017/9724371
52. Covic T, Adamson B, Hough M. The impact of passive coping on rheumatoid arthritis pain. Rheumatology (Oxford) 2000; 39 (9): 1027-1030. doi: 10.1093/rheumatology/39.9.1027